Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool.
Systematic reviews of the effects of healthcare interventions frequently include non-randomized studies. These are subject to confounding and a range of other biases that are seldom considered in detail when synthesizing and interpreting the results. Our aims were to assess the reliability and usabi...
Main Authors: | Anja Bilandzic, Tiffany Fitzpatrick, Laura Rosella, David Henry |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-04-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC4821619?pdf=render |
Similar Items
-
Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies
by: Gøtzsche Peter C, et al.
Published: (2008-04-01) -
Poor reliability between Cochrane reviewers and blinded external reviewers when applying the Cochrane risk of bias tool in physical therapy trials.
by: Susan Armijo-Olivo, et al.
Published: (2014-01-01) -
Risk of bias judgments for random sequence generation in Cochrane systematic reviews were frequently not in line with Cochrane Handbook
by: Ognjen Barcot, et al.
Published: (2019-08-01) -
The effect of the CONSORT statement on the amount of "unclear" Risk of Bias reporting in Cochrane Systematic Reviews.
by: Maaike M Rademaker, et al.
Published: (2020-01-01) -
Risk of bias judgements and strength of conclusions in meta-evidence from the Cochrane Colorectal Cancer Group
by: John Delaney, et al.
Published: (2019-04-01)